Do not share your Fiasp® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
When to consider NovoLog®
Millions of people with both type 1 and type 2 diabetes have taken NovoLog® to help reach their A1C goals since 2001. Ask your health care provider if NovoLog® is an option for you.
NovoLog® may be used by a broad range of patients
NovoLog® is a rapid-acting mealtime insulin that helps lower mealtime blood sugar spikes in adults and children with diabetes. It has been proven to help control high blood sugar in people with diabetes when taken with a long-acting insulin.
Pediatric patients
NovoLog® is approved for type 1 diabetes in children as young as 2 years of age.
Insulin pump users
NovoLog® is approved for use in insulin pumps in children aged 2 and older with type 1 diabetes and adults with diabetes. View device options ›
NovoLog® is usually prescribed as part of a basal-bolus therapy
Basal-bolus insulin therapy uses 2 types of insulin to more closely mimic the body’s normal insulin release. Basal-bolus insulin therapy is recommended for people with type 1 diabetes and for people with type 2 diabetes who need more blood sugar control than basal insulin alone can provide. Learn more about these 2 types of therapy ›